News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
Wyeth Deal Could Mean NJ Drug Industry Job Cuts
February 2, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEWARK, N.J. (AP) -- The state known as the nation's medicine chest is bleeding from sweeping job cuts to its high-paying pharmaceutical industry.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
Mergers & acquisitions
Pfizer
MORE ON THIS TOPIC
Job Trends
Pharmas face off for manufacturing talent amidst reshoring efforts
September 23, 2026
·
5 min read
·
Angela Gabriel
Job Trends
9 companies hiring in Pennsylvania now
September 23, 2026
·
1 min read
·
Angela Gabriel
C-suite
Novo’s plan to hit $23B in revenue by 2035 leaves investors wanting
September 21, 2026
·
5 min read
·
Annalee Armstrong
Mergers & acquisitions
Telix buys ITM for $1.65B in ‘supercritical’ radiopharma M&A
September 21, 2026
·
3 min read
·
Tristan Manalac
